| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| State: | White Powder |
| Purity: | >99% |
| CAS: | 5536-17-4 |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| English name | Vidarabine |
| CAS | 5536-17-4 |
| MF | C10H13N5O4 |
| MW | 267.24 |
| EINECS | 226-893-9 |
| Melting point | 260-265 °C (dec.) |
| Boiling point | 410.43°C |
| Density | 1.3382 |
| Storage | −20°C |
1. Antiarrhythmic drugs can turn paroxysmal supraventricular tachycardia into sinus rhythm. For supraventricular arrhythmias associated with atrioventricles.
2. Antiviral drugs.
3. In the pharmaceutical industry, it is mainly used to produce the main raw materials of drugs such as adenosine arabinose, adenosine triphosphate, coenzyme and its series products adenosine cyclophosphate.
4. Used in the manufacture of ATP, adenosine arabinose, coenzyme A, etc. 5. Treatment of angina pectoris, myocardial infarction, coronary insufficiency, arteriosclerosis, essential hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscle atrophy, etc. Atrioventricular block and acute myocardial infarction are prohibited.
|
Items |
Standard |
Result |
|
Description |
White, tiny needle-shaped crystal or crystalline powder; odourless, tasteless |
Complies |
|
Identification |
(1)show positive reaction |
Complies |
|
(2)the retention time complies to standard |
||
|
(3)max absorption at 259nm; min absorption at 228nm; |
||
|
(4)Infrared absorption |
||
|
PH |
6.0-7.0 |
6.5 |
|
Transmission |
≥98.0% |
99.9% |
|
Relate impurities |
≤1.0% |
0.2% |
|
Loss on drying |
≤0.5% |
0.1% |
|
Residue on ignition |
≤0.1% |
0.1% |
|
Heavy metals |
10ppm |
Complies |
|
Specific rotation |
-56.0 º ~65.0º |
58.5º |
|
Assay(HPLC) |
98.0%~102.0% |
99.8% |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}